NSG 420 - ATI Pharm focused review Exam (elaborations)
NSG 420 - ATI Pharm focused review Exam (elaborations) 1. Substance Use and Other Disorders and Dependencies - (1) a. Substance Use Disorders: Expected Prescription for Smoking Cessation (Active Learning Template - Medication, RM Pharm RN 8.0 Chp 12) i. Bupropion should not be used with patients who have an increased risk of seizures. ii. Patients that use bupropion should avoid caffeine and other stimulants to avoid insomnia. iii. The intended effects of bupropion are to decrease cravings for nicotine and lessen the effects of withdrawal.
Geschreven voor
- Instelling
- Stratford University
- Vak
- NSG 420
Documentinformatie
- Geüpload op
- 19 januari 2023
- Aantal pagina's
- 7
- Geschreven in
- 2022/2023
- Type
- Tentamen (uitwerkingen)
- Bevat
- Vragen en antwoorden
Onderwerpen
-
nsg 420
-
nsg 420
-
ati pharm focused review
-
ati pharm focused
-
nsg 420 ati pharm focused review exam elaborations
-
nsg 420 ati pharm focused review
-
nsg 420 ati pharm focused
-
1 substance use and